Newsfeeds - Spark Newswire

7 minute read

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results

Today, 2:40 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6)

ADVM

1 minute read

Mesoblast Reported Late Wednesday Rexlemestrocel-L Phase 3 Trial Results in Chronic Heart Failure Selected as Late Breaking Presentation at American Heart Association Annual Meeting GLN

By Charles Gross

Today, 2:40 PM

Mesoblast Limited (NASDAQ: MESO) announced that results from the randomized, controlled Phase 3 trial of rexlemestrocel-L in 565 patients with New York Heart Association (NYHA) class II and class III chronic heart failure (CHF) with low ejection fraction (HFrEF) have been selected through peer review as a late breaking present

MESO

5 minute read

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer’s Sleep Disorder Drug Filing Accepted For Review, Voyager’s Licensing Options Deal

By Shanthi Rexaline

Today, 2:40 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5)

ABEO

6 minute read

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data

By Shanthi Rexaline

Today, 2:40 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20)

ABSI

5 minute read

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab

By Shanthi Rexaline

Today, 2:40 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1)

ABBV

4 minute read

54 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:40 PM

Gainers Focus Universal Inc. (NASDAQ: FCUV) shares climbed 278% to close at $19.28 on Wednesday. The stock started trading on Nasdaq Capital Market yesterday.

AAMC

3 minute read

38 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 2:40 PM

Gainers Focus Universal Inc. (NASDAQ: FCUV) shares jumped 108.2% to $10.62. The stock started trading on Nasdaq Capital Market yesterday.

AAMC

1 minute read

Chardan Capital Maintains Sell on Mesoblast, Lowers Price Target to $6.5

By vishwanath@benzinga.com

Today, 2:40 PM

Chardan Capital analyst Keay Nakae maintains Mesoblast (NASDAQ:MESO) with a Sell and lowers the price target from $7.5 to $6.5.

MESO

3 minute read

Longeveron’s Novel Therapy Looks to Tackle COVID-19, Flu-Related ARDS

By Emily Cervone

Today, 2:40 PM

Photo by Anna Shvets from Pexels

ATHX

1 minute read

Mesoblast Shares 90-Day Survival Outcomes After Remestemcel-L From COVID-19 ARDS Trial

By Vandana Singh

Today, 2:40 PM

Mesoblast Limited (NASDAQ:MESO) has announced the presentation of 90-day survival outcomes from the remestemcel-L trial in ventilator-dependent COVID-19 patients with moderate/severe…

MESO